Auflistung Nach Schlagwort "proprotein convertase subtilisin kexin type 9 inhibitor"
Anzeige der Dokumente 1-1 von 1
-
Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
(2016)Two proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, evolocumab and alirocumab, have recently been approved by both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the ...